
​Haleon plc: Director/PDMR Shareholding
17 March 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by a Person Discharging Managerial Responsibilities ("PDMR").
This notification sets out the details of the vesting of Haleon share awards over ordinary shares and American Despositary Shares ("ADS") made to PDMRs in October 2022 under the Haleon Performance Share Plan 2022 and Share Value Plan 2022 and the subsequent sale of ordinary shares and ADS to meet tax liabilities.
The awards under the Performance Share Plan include dividends accrued and were conditional on continued employment and on the satisfaction of the performance conditions over the performance period ended on 31 December 2024 approved by the Remuneration Committee, which (after tax on the gross award) must be retained until the shareholding requirement is met, and in any event for Executive Directors two years after receipt.
The award under the Share Value Plan was conditional on continued employment and must be retained until the shareholding requirement is met after receipt.
Performance targets and levels of achievement will be disclosed in the 2024 Annual Report and 20-F. All awards are subject to malus and clawback provisions.
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Keith Choy | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| President, Asia Pacific | ||||
b)
| Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a)
| Name
| Haleon plc | ||||
b)
| LEI
| 549300PSB3WWEODCUP19 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each | ||||
| | |||||
Identification code | GB00BMX86B70 | |||||
| | |||||
b)
| Nature of the transaction
| (i) Acquisition of Ordinary Shares in respect of the Haleon plc Share Value Plan. (ii) Acquisition of Ordinary Shares in respect of the Haleon plc Performance Share Plan.
| ||||
c)
| Price(s) and volume(s) | | | | | |
| | | Price(s) | Volume(s) | | |
| | (i) | Nil | 11,196.00 | | |
| | (ii) | Nil | 574,981.73 | | |
| | | | | ||
d)
| Aggregated information | | ||||
| | |||||
- Aggregated volume | 586,177.73 | |||||
| | |||||
- Price | N/A | |||||
| | |||||
e)
| Date of the transaction
| 14 March 2025 | ||||
f)
| Place of the transaction
| Outside a trading venue
|
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Filippo Lanzi | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| President, EMEA and LATAM | ||||
b)
| Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a)
| Name
| Haleon plc | ||||
b)
| LEI
| 549300PSB3WWEODCUP19 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each | ||||
| | |||||
Identification code | GB00BMX86B70 | |||||
| | |||||
b)
| Nature of the transaction
| Acquisition of Ordinary Shares in respect of the Haleon plc Performance Share Plan.
| ||||
c)
| Price(s) and volume(s) | | | | | |
| | | Price(s) | Volume(s) | | |
| | | Nil | 521,251.16 | | |
| | | | | ||
d)
| Aggregated information | | ||||
| | |||||
- Aggregated volume | N/A | |||||
| | |||||
- Price | | |||||
| | |||||
e)
| Date of the transaction
| 14 March 2025 | ||||
f)
| Place of the transaction
| Outside a trading venue
| ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each | ||||
| | |||||
Identification code | GB00BMX86B70 | |||||
| | |||||
b)
| Nature of the transaction
| Automatic disposal of Ordinary Shares resulting from the Haleon plc Performance Share Plan vesting to cover tax liabilities.
| ||||
c)
| Price(s) and volume(s) | | | | | |
| | | Price(s) | Volume(s) | | |
| | | £3.868843 | 239,840.19 | | |
| | | | | ||
d)
| Aggregated information | | ||||
| | |||||
- Aggregated volume | N/A | |||||
| | |||||
- Price | | |||||
| | |||||
e)
| Date of the transaction
| 14 March 2025 | ||||
f)
| Place of the transaction
| London Stock Exchange (XLON) 
|
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Brian McNamara | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Chief Executive Officer | ||||
b)
| Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a)
| Name
| Haleon plc | ||||
b)
| LEI
| 549300PSB3WWEODCUP19 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each | ||||
| | |||||
Identification code | GB00BMX86B70 | |||||
| | |||||
b)
| Nature of the transaction
| Acquisition of Ordinary Shares in respect of the Haleon plc Performance Share Plan.
| ||||
c)
| Price(s) and volume(s) | | | | | |
| | | Price(s) | Volume(s) | | |
| | | Nil | 1,604,522.15 | | |
| | | | | ||
d)
| Aggregated information | | ||||
| | |||||
- Aggregated volume | N/A | |||||
| | |||||
- Price | | |||||
| | |||||
e)
| Date of the transaction
| 14 March 2025 | ||||
f)
| Place of the transaction
| Outside a trading venue
| ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each | ||||
| | |||||
Identification code | GB00BMX86B70 | |||||
| | |||||
b)
| Nature of the transaction
| Automatic disposal of Ordinary Shares resulting from the Haleon plc Performance Share Plan vesting to cover tax liabilities.
| ||||
c)
| Price(s) and volume(s) | | | | | |
| | | Price(s) | Volume(s) | | |
| | | £3.868843 | 755,258.30 | | |
| | | | | ||
d)
| Aggregated information | | ||||
| | |||||
- Aggregated volume | N/A | |||||
| | |||||
- Price | | |||||
| | |||||
e)
| Date of the transaction
| 14 March 2025 | ||||
f)
| Place of the transaction
| London Stock Exchange (XLON) 
|
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Lisa Paley | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| President, North America | ||||
b)
| Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a)
| Name
| Haleon plc | ||||
b)
| LEI
| 549300PSB3WWEODCUP19 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument | Haleon plc American Depositary Shares (ADS)
| ||||
| | |||||
Identification code | US4055521003 | |||||
| | |||||
b)
| Nature of the transaction
| Acquisition of ADS in respect of the Haleon plc Performance Share Plan.
| ||||
c)
| Price(s) and volume(s) | | | | | |
| | | Price(s) | Volume(s) | | |
| | | Nil | 289,881.02 | | |
| | | | | ||
d)
| Aggregated information | | ||||
| | |||||
- Aggregated volume | N/A | |||||
| | |||||
- Price | | |||||
| | |||||
e)
| Date of the transaction
| 14 March 2025 | ||||
f)
| Place of the transaction
| Outside a trading venue
| ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument | Haleon plc American Depositary Shares (ADS)
| ||||
| | |||||
Identification code | US4055521003 | |||||
| | |||||
b)
| Nature of the transaction
| Automatic disposal of ADS resulting from the Haleon plc Performance Share Plan vesting to cover tax liabilities.
| ||||
c)
| Price(s) and volume(s) | | | | | |
| | | Price(s) | Volume(s) | | |
| | | $10.1543 | 135,511.22 | | |
| | | | | ||
d)
| Aggregated information | | ||||
| | |||||
- Aggregated volume | N/A | |||||
| | |||||
- Price | | |||||
| | |||||
e)
| Date of the transaction
| 14 March 2025 | ||||
f)
| Place of the transaction
| New York Stock Exchange (XNYS)
|
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Franck Riot | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Chief R&D Officer | ||||
b)
| Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a)
| Name
| Haleon plc | ||||
b)
| LEI
| 549300PSB3WWEODCUP19 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each | ||||
| | |||||
Identification code | GB00BMX86B70 | |||||
| | |||||
b)
| Nature of the transaction
| Acquisition of Ordinary Shares in respect of the Haleon plc Performance Share Plan.
| ||||
c)
| Price(s) and volume(s) | | | | | |
| | | Price(s) | Volume(s) | | |
| | | Nil | 393,642.90 | | |
| | | | | ||
d)
| Aggregated information | | ||||
| | |||||
- Aggregated volume | N/A | |||||
| | |||||
- Price | | |||||
| | |||||
e)
| Date of the transaction
| 14 March 2025 | ||||
f)
| Place of the transaction
| Outside a trading venue
| ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each | ||||
| | |||||
Identification code | GB00BMX86B70 | |||||
| | |||||
b)
| Nature of the transaction
| Automatic disposal of Ordinary Shares resulting from the Haleon plc Performance Share Plan vesting to cover tax liabilities.
| ||||
c)
| Price(s) and volume(s) | | | | | |
| | | Price(s) | Volume(s) | | |
| | | £3.868843 | 185,290.10 | | |
| | | | | ||
d)
| Aggregated information | | ||||
| | |||||
- Aggregated volume | N/A | |||||
| | |||||
- Price | | |||||
| | |||||
e)
| Date of the transaction
| 14 March 2025 | ||||
f)
| Place of the transaction
| London Stock Exchange (XLON) 
|
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Tamara Rogers | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Chief Marketing Officer | ||||
b)
| Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a)
| Name
| Haleon plc | ||||
b)
| LEI
| 549300PSB3WWEODCUP19 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each | ||||
| | |||||
Identification code | GB00BMX86B70 | |||||
| | |||||
b)
| Nature of the transaction
| Acquisition of Ordinary Shares in respect of the Haleon plc Performance Share Plan.
| ||||
c)
| Price(s) and volume(s) | | | | | |
| | | Price(s) | Volume(s) | | |
| | | Nil | 483,987.00 | | |
| | | | | ||
d)
| Aggregated information | | ||||
| | |||||
- Aggregated volume | N/A | |||||
| | |||||
- Price | | |||||
| | |||||
e)
| Date of the transaction
| 14 March 2025 | ||||
f)
| Place of the transaction
| Outside a trading venue
| ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each | ||||
| | |||||
Identification code | GB00BMX86B70 | |||||
| | |||||
b)
| Nature of the transaction
| Automatic disposal of Ordinary Shares resulting from the Haleon plc Performance Share Plan vesting to cover tax liabilities.
| ||||
c)
| Price(s) and volume(s) | | | | | |
| | | Price(s) | Volume(s) | | |
| | | £3.868843 | 227,815.61 | | |
| | | | | ||
d)
| Aggregated information | | ||||
| | |||||
- Aggregated volume | N/A | |||||
| | |||||
- Price | | |||||
| | |||||
e)
| Date of the transaction
| 14 March 2025 | ||||
f)
| Place of the transaction
| London Stock Exchange (XLON) 
|
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.